Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies

NCT00295243 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: Topotecan

Sponsor

Mayo Clinic

Collaborators

[object Object]